CP
EMN icon

Castleview Partners’s Eastman Chemical EMN Stock Holding History

Castleview Partners’s Portfolio EMN Stock Details EMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-4
Closed -$392 – 650
2024
Q2 		$392 Hold
4
– – ﹤0.01% 859
2024
Q1 		$401 Hold
4
– – ﹤0.01% 845
2023
Q4 		$359 Buy
+4
New +$319 ﹤0.01% 819
2021
Q2 		$17K Buy
+146
New +$17.5K 0.01% 582

Other funds holding EMN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Castleview Partners's EMN Position: Q3 2024 in Review

Castleview Partners sold out of Eastman Chemical (EMN) in Q3 2024, closing a stake of 4 shares — an estimated $392 sold.

Castleview Partners first reported a position in EMN in Q2 2021 and held it in 4 quarters. The position peaked at $17K in Q2 2021. 782 funds tracked by Wall St. Rank hold EMN as of Q3 2024.

  • Castleview Partners reported no remaining Eastman Chemical position as of Q3 2024 after selling out during the quarter.
  • Castleview Partners sold 4 Eastman Chemical shares in Q3 2024, an estimated $392.
  • Castleview Partners first reported a position in Eastman Chemical in Q2 2021 and held it in 4 quarters.
  • Castleview Partners's Eastman Chemical position peaked at $17K in Q2 2021.
  • 782 funds tracked by Wall St. Rank held Eastman Chemical as of Q3 2024.

Based on Castleview Partners's 13F filing for Q3 2024, filed 9 Oct 2024.